A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease - Concepedia

Concepedia

Publication | Open Access

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

DOI Full Paper Access

50

Citations

32

References

2011

Year

Yu Nakamura, Yukimichi Imai, Masahiro Shigeta, Ana Graf, Toru Shirahase, Hyosung Kim, Akifumi Fujii, Joji Mori, Akira Homma

Dementia and Geriatric Cognitive Disorders Extra

Abstract

The rivastigmine patch has a favorable efficacy and tolerability profile in Japanese patients with AD.

References

	Year	Citations

Page 1